|Bid||4.9900 x 0|
|Ask||5.0000 x 0|
|Day's Range||4.9800 - 5.0000|
|52 Week Range||2.3500 - 5.0800|
|Beta (5Y Monthly)||3.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.67|
The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...
WELL Health Technologies Corp. (TSX: WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the healthcare sector, is pleased to announce that on April 16, 2021, the securityholders of CRH Medical Corporation ("CRH") (TSX: CRH) (NYSE: CRHM) approved the acquisition of CRH by a subsidiary of WELL for US$4.00 per share in cash (the "Acquisition"). As previously announced on February 8, 2021, this Acquisition represents an equity consideration of approximately US$292.7 million and a transaction value of approximately US$369.2 million, inclusive of CRH's credit facility. The Acquisition is subject to court and regulatory approvals and clearances, as well as other customary closing conditions. Subject to the satisfaction of such conditions, the Acquisition is expected to be completed on or about April 22, 2021.
CRH Medical Corporation (TSX: CRH) (NYSE: CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today.